157 related articles for article (PubMed ID: 30701862)
1. Effect of N-acetylcysteine on mucosal immunity of respiratory tract.
Kalyuzhin OV
Ter Arkh; 2018 Apr; 90(3):89-95. PubMed ID: 30701862
[TBL] [Abstract][Full Text] [Related]
2. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.
Tomkiewicz RP; App EM; De Sanctis GT; Coffiner M; Maes P; Rubin BK; King M
Pulm Pharmacol; 1995 Dec; 8(6):259-65. PubMed ID: 8819180
[TBL] [Abstract][Full Text] [Related]
3. Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler in dogs: airway epithelial function changes.
Tomkiewicz RP; App EM; Coffiner M; Fossion J; Maes P; King M
Eur Respir J; 1994 Jan; 7(1):81-7. PubMed ID: 8143836
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells.
Rochat T; Lacroix JS; Jornot L
J Cell Physiol; 2004 Oct; 201(1):106-16. PubMed ID: 15281093
[TBL] [Abstract][Full Text] [Related]
5. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
[TBL] [Abstract][Full Text] [Related]
6. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells.
Seagrave J; Albrecht HH; Hill DB; Rogers DF; Solomon G
Respir Res; 2012 Oct; 13(1):98. PubMed ID: 23113953
[TBL] [Abstract][Full Text] [Related]
7. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.
Dorow P; Weiss T; Felix R; Köhler M
Arzneimittelforschung; 1986; 36(1):131-3. PubMed ID: 3954815
[TBL] [Abstract][Full Text] [Related]
8. Effect of myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters.
Begrow F; Böckenholt C; Ehmen M; Wittig T; Verspohl EJ
Adv Ther; 2012 Apr; 29(4):350-8. PubMed ID: 22477544
[TBL] [Abstract][Full Text] [Related]
9. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone and N-acetyl-cysteine attenuate Pseudomonas aeruginosa-induced mucus expression in human airways.
Sprenger L; Goldmann T; Vollmer E; Steffen A; Wollenberg B; Zabel P; Hauber HP
Pulm Pharmacol Ther; 2011 Apr; 24(2):232-9. PubMed ID: 21146625
[TBL] [Abstract][Full Text] [Related]
11. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
De Lisle RC; Roach E; Jansson K
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
[TBL] [Abstract][Full Text] [Related]
12. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.
Blasi F; Page C; Rossolini GM; Pallecchi L; Matera MG; Rogliani P; Cazzola M
Respir Med; 2016 Aug; 117():190-7. PubMed ID: 27492531
[TBL] [Abstract][Full Text] [Related]
13. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro.
Riise GC; Qvarfordt I; Larsson S; Eliasson V; Andersson BA
Respiration; 2000; 67(5):552-8. PubMed ID: 11070462
[TBL] [Abstract][Full Text] [Related]
15. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus.
Martin R; Litt M; Marriott C
Am Rev Respir Dis; 1980 Mar; 121(3):495-500. PubMed ID: 6968166
[TBL] [Abstract][Full Text] [Related]
16. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
17. [The application of N-acetylcysteine in optimization of specific pharmacological therapies].
Hołyńska-Iwan I; Wróblewski M; Olszewska-Słonina D; Tyrakowski T
Pol Merkur Lekarski; 2017 Sep; 43(255):140-144. PubMed ID: 28987048
[TBL] [Abstract][Full Text] [Related]
18. Tracheobronchial function in health and disease. Effect of mucolytic substances.
Melville GN; Ismail S; Sealy C
Respiration; 1980; 40(6):329-36. PubMed ID: 7221201
[TBL] [Abstract][Full Text] [Related]
19. Effects of N-acetyl-L-cysteine on the membrane vesicle release and growth of respiratory pathogens.
Volgers C; Benedikter BJ; Grauls GE; Hellebrand PHM; Savelkoul PHM; Stassen FRM
FEMS Microbiol Lett; 2017 May; 364(9):. PubMed ID: 28444395
[TBL] [Abstract][Full Text] [Related]
20. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
Calzetta L; Matera MG; Rogliani P; Cazzola M
Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]